Why is GAAP net income so much higher for the nine months than for the quarter?

Nine-month GAAP net income of $2.22 billion includes a $1.55 billion income tax benefit, mainly from releasing a valuation allowance on U.S. federal, non-California state, and U.K. deferred tax assets. This is a one-time, largely non-cash accounting benefit that reflects the company's improved expected ability to use those tax assets. Operating income for the nine months was $445.5 million, a much smaller figure.

How is the business growing, and is the growth recurring?

Growth is driven mainly by subscription and support revenue, which rose 20% to $1.59 billion in Q3 and is recognized ratably over the contract term. Remaining performance obligation grew 23% to $11.3 billion, which supports revenue visibility. Product revenue was roughly flat at $391 million, up slightly from $388 million.

Did guidance change, and what does it imply for the rest of the year?

Full-year revenue guidance is $7.99 to $8.01 billion, about 16% growth, and billings guidance is $10.13 to $10.18 billion, or 10% to 11% growth. The company did not provide a GAAP EPS outlook. Fourth-quarter revenue is guided to $2.15 to $2.17 billion (10% to 11% growth), which is slower than the year-to-date pace, and billings growth is also expected to slow to 9% to 10%.

How should investors view the non-GAAP adjustments?

The largest adjustment is share-based compensation, about $290 million in Q3 and $875 million over nine months. It is a recurring cost of paying employees, so excluding it flatters profitability. Other adjustments include amortization of acquired intangibles, acquisition costs, litigation charges, and a tax adjustment at a long-term non-GAAP tax rate. Investors should compare GAAP and non-GAAP figures together and not rely on either alone.

PANW 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed May 20, 2024. Cited figures are marked; the original filing is the authoritative source.

Palo Alto Networks reported fiscal third quarter 2024 (ended April 30, 2024) revenue of $1.98 billion^a, up 15% year over year from $1.72 billion.

Subscription and support revenue rose 20% to $1.59 billion^b and now makes up about 80% of the quarter's revenue. Remaining performance obligation grew 23% to $11.3 billion, and non-GAAP operating margin expanded 200 basis points to 25.6% per the reconciliation table (the headline rounds this to 26%). Non-GAAP diluted EPS was $1.32, up from $1.10.

GAAP net income was $278.8 million^c, or $0.79 per diluted share, versus $107.8 million, or $0.31, a year earlier. Management attributed the results to customer adoption of its platformization strategy and continued investment in go-to-market and innovation. The headline GAAP figures for the nine months need careful reading.

Nine-month GAAP net income of $2.22 billion^d is inflated by a $1.55 billion income tax benefit, driven mainly by the release of a valuation allowance on U.S. federal, non-California state, and U.K. deferred tax assets. Deferred tax assets rose from $23 million at July 31, 2023 to $2.29 billion at April 30, 2024. This is a largely non-cash, non-recurring item, and it should not be read as operating earnings.

Nine-month litigation-related charges of $186 million also weighed on GAAP results. Full-year guidance was updated. Fiscal 2024 revenue is now expected at $7.99 to $8.01 billion (about 16% growth), billings at $10.13 to $10.18 billion (10% to 11% growth), non-GAAP operating margin at 26.8% to 27.0%, non-GAAP diluted EPS at $5.56 to $5.58, and adjusted free cash flow margin at 38.5% to 39.0%.

For the fourth quarter, the company guided to revenue of $2.15 to $2.17 billion (10% to 11% growth) and non-GAAP EPS of $1.40 to $1.42. Investors should weigh the strong recurring revenue and backlog growth against the one-time nature of the tax benefit and the lower billings growth implied for the remainder of the year.

02—Key points

Key Highlights

Q3 FY2024 revenue rose 15% year over year to $1.98 billion, with subscription and support revenue up 20% to $1.59 billion (about 80% of total revenue).
Remaining performance obligation grew 23% year over year to $11.3 billion, signaling strong forward revenue visibility.
Non-GAAP operating margin improved 200 bps to 25.6% in Q3; non-GAAP diluted EPS rose 20% to $1.32 from $1.10.
GAAP net income of $278.8 million ($0.79 per diluted share) in Q3 included a tax benefit; nine-month GAAP net income of $2.22 billion was driven by a $1.55 billion tax benefit from releasing a valuation allowance on deferred tax assets, which is largely non-cash and non-recurring.
Full-year FY2024 revenue guidance is $7.99 to $8.01 billion (about 16% growth), and non-GAAP EPS guidance is $5.56 to $5.58, with billings guided to 10% to 11% growth.
Q4 FY2024 guidance calls for revenue of $2.15 to $2.17 billion (10% to 11% growth) and non-GAAP EPS of $1.40 to $1.42.
Nine-month litigation-related charges of $185.9 million and rising non-current deferred tax assets are items to monitor; convertible senior notes due within the year total $1.16 billion, against cash and investments of about $6.4 billion.

03—Questions

Frequently Asked Questions

Why is GAAP net income so much higher for the nine months than for the quarter?
Nine-month GAAP net income of $2.22 billion includes a $1.55 billion income tax benefit, mainly from releasing a valuation allowance on U.S. federal, non-California state, and U.K. deferred tax assets. This is a one-time, largely non-cash accounting benefit that reflects the company's improved expected ability to use those tax assets. Operating income for the nine months was $445.5 million, a much smaller figure.
How is the business growing, and is the growth recurring?
Growth is driven mainly by subscription and support revenue, which rose 20% to $1.59 billion in Q3 and is recognized ratably over the contract term. Remaining performance obligation grew 23% to $11.3 billion, which supports revenue visibility. Product revenue was roughly flat at $391 million, up slightly from $388 million.
Did guidance change, and what does it imply for the rest of the year?
Full-year revenue guidance is $7.99 to $8.01 billion, about 16% growth, and billings guidance is $10.13 to $10.18 billion, or 10% to 11% growth. The company did not provide a GAAP EPS outlook. Fourth-quarter revenue is guided to $2.15 to $2.17 billion (10% to 11% growth), which is slower than the year-to-date pace, and billings growth is also expected to slow to 9% to 10%.
How should investors view the non-GAAP adjustments?
The largest adjustment is share-based compensation, about $290 million in Q3 and $875 million over nine months. It is a recurring cost of paying employees, so excluding it flatters profitability. Other adjustments include amortization of acquired intangibles, acquisition costs, litigation charges, and a tax adjustment at a long-term non-GAAP tax rate. Investors should compare GAAP and non-GAAP figures together and not rely on either alone.

04—Continue

← View all 8-K filings